Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043
Article in Nature Communications (February 2024)
The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.
Article in Nature Communications (February 2024)
Article in Frontiers in Oncology (June 2022)
Article in Neuro-Oncology (April 2022)